The algorithm can be used to select features of cells of interest from other single-cell data types, such as proteins, or even from non-single-cell datasets.
Federal Court Whittles Down Fluidigm Lawsuit Against IonPath
A federal judge granted IonPath's motion to dismiss portions of Fluidigm's suit but claims of direct infringement were untouched and will proceed.
Fluidigm Q3 Revenues Fall 9 Percent on Mass Cytometry Weakness
Fluidigm logged $26.4 million in revenues compared to $29.0 million a year ago and well short of analysts' consensus estimate of $28.7 million.
New Products: May 28, 2010
ASMS Focus: New Products from Thermo Fisher, Bruker, Waters, Shimadzu, Agilent, and Bio-Rad
It was not immediately clear whether PerkinElmer would divest all of its proteomics assets or retain a portion of them, though it described them as “discontinued operations” during its fourth-quarter earnings statement.